Patricia C. Ryan

1.8k total citations
32 papers, 1.3k citations indexed

About

Patricia C. Ryan is a scholar working on Oncology, Immunology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Patricia C. Ryan has authored 32 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 10 papers in Immunology and 9 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Patricia C. Ryan's work include Monoclonal and Polyclonal Antibodies Research (9 papers), Virus-based gene therapy research (6 papers) and CAR-T cell therapy research (6 papers). Patricia C. Ryan is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (9 papers), Virus-based gene therapy research (6 papers) and CAR-T cell therapy research (6 papers). Patricia C. Ryan collaborates with scholars based in United States, United Kingdom and Switzerland. Patricia C. Ryan's co-authors include David E. Draper, Ya‐Wen Chiang, Ming Lu, D. Close, Wendy I. White, A. Godwood, Antonina Rait, Gerard J. McGarrity, Kathleen F. Pirollo and Willard E. Fee and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Molecular Biology and Biochemistry.

In The Last Decade

Patricia C. Ryan

32 papers receiving 1.3k citations

Peers

Patricia C. Ryan
Raffaella Ghittoni Italy
Ralph F. Hopkins United States
Marco Bestagno Italy
Mercedes Porosnicu United States
Maria Ferrantini Italy
Purnima Dubey United States
Valeri H. Terry United States
Ezequiel M. Fuentes‐Pananá Mexico
Isabel Fofana France
Andrea S. Llera Argentina
Raffaella Ghittoni Italy
Patricia C. Ryan
Citations per year, relative to Patricia C. Ryan Patricia C. Ryan (= 1×) peers Raffaella Ghittoni

Countries citing papers authored by Patricia C. Ryan

Since Specialization
Citations

This map shows the geographic impact of Patricia C. Ryan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patricia C. Ryan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patricia C. Ryan more than expected).

Fields of papers citing papers by Patricia C. Ryan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patricia C. Ryan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patricia C. Ryan. The network helps show where Patricia C. Ryan may publish in the future.

Co-authorship network of co-authors of Patricia C. Ryan

This figure shows the co-authorship network connecting the top 25 collaborators of Patricia C. Ryan. A scholar is included among the top collaborators of Patricia C. Ryan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patricia C. Ryan. Patricia C. Ryan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Buss, Nicholas, Patricia C. Ryan, Todd M. Baughman, et al.. (2018). Nonclinical safety and pharmacokinetics of Miglyol 812: A medium chain triglyceride in exenatide once weekly suspension. Journal of Applied Toxicology. 38(10). 1293–1301. 14 indexed citations
2.
Weinblatt, Michael E., Iain B. McInnes, Joel M. Kremer, et al.. (2017). A Randomized Phase II b Study of Mavrilimumab and Golimumab in Rheumatoid Arthritis. Arthritis & Rheumatology. 70(1). 49–59. 72 indexed citations
3.
Zhu, Qing, Jason S. McLellan, Nicole L. Kallewaard, et al.. (2017). A highly potent extended half-life antibody as a potential RSV vaccine surrogate for all infants. Science Translational Medicine. 9(388). 232 indexed citations
4.
Burmester, Gerd R, Iain B. McInnes, Joel M. Kremer, et al.. (2017). A randomised phase IIb study of mavrilimumab, a novel GM–CSF receptor alpha monoclonal antibody, in the treatment of rheumatoid arthritis. Annals of the Rheumatic Diseases. 76(6). 1020–1030. 105 indexed citations
5.
Guo, Xiang, Brandon W. Higgs, Anne‐Christine Bay‐Jensen, et al.. (2017). Blockade of GM-CSF pathway induced sustained suppression of myeloid and T cell activities in rheumatoid arthritis. Lara D. Veeken. 57(1). 175–184. 28 indexed citations
6.
Nicholson, Simone M., Gianluca Carlesso, Lily Cheng, et al.. (2017). Effects of ICOS+ T cell depletion via afucosylated monoclonal antibody MEDI-570 on pregnant cynomolgus monkeys and the developing offspring. Reproductive Toxicology. 74. 116–133. 10 indexed citations
7.
Grimaldi, Christine, Deborah Finco, Madeline Fort, et al.. (2016). Cytokine release: A workshop proceedings on the state-of-the-science, current challenges and future directions. Cytokine. 85. 101–108. 32 indexed citations
8.
Pishvaian, Michael J., Michael A. Morse, Jennifer McDevitt, et al.. (2016). Phase 1 Dose Escalation Study of MEDI-565, a Bispecific T-Cell Engager that Targets Human Carcinoembryonic Antigen, in Patients With Advanced Gastrointestinal Adenocarcinomas. Clinical Colorectal Cancer. 15(4). 345–351. 73 indexed citations
9.
Auletta, Carol S., et al.. (2015). Cytokines. International Journal of Toxicology. 34(4). 355–365. 68 indexed citations
10.
Ryan, Patricia C., Matthew A. Sleeman, Marlon C. Rebelatto, et al.. (2014). Nonclinical safety of mavrilimumab, an anti-GMCSF receptor alpha monoclonal antibody, in cynomolgus monkeys: Relevance for human safety. Toxicology and Applied Pharmacology. 279(2). 230–239. 14 indexed citations
11.
Dixit, Rakesh, Laurie Iciek, Kathleen McKeever, & Patricia C. Ryan. (2009). Challenges of general safety evaluations of biologics compared to small molecule pharmaceuticals in animal models. Expert Opinion on Drug Discovery. 5(1). 79–94. 9 indexed citations
12.
Mulgrew, Kathy, David J. Stewart, Wendy L. Trigona, et al.. (2008). Bioavailability, pharmacodynamic activity, and anti-tumor efficacy of the CD19/CD3-specific BiTE antibody MEDI-538 (MT103) delivered subcutaneously in animal models. Cancer Research. 68. 2131–2131. 2 indexed citations
13.
Ryan, Patricia C., John Jakubczak, David A. Stewart, et al.. (2004). Antitumor efficacy and tumor-selective replication with a single intravenous injection of OAS403, an oncolytic adenovirus dependent on two prevalent alterations in human cancer. Cancer Gene Therapy. 11(8). 555–569. 36 indexed citations
14.
Kim, Jin, Theodore A Smith, Neeraja Idamakanti, et al.. (2002). Targeting Adenoviral Vectors by Using the Extracellular Domain of the Coxsackie-Adenovirus Receptor: Improved Potency via Trimerization. Journal of Virology. 76(4). 1892–1903. 37 indexed citations
15.
Long, Zhifeng, Stephen N. Mueller, Patricia C. Ryan, et al.. (1998). Biosafety Monitoring of Patients Receiving Intracerebral Injections of Murine Retroviral Vector Producer Cells. Human Gene Therapy. 9(8). 1165–1172. 44 indexed citations
16.
Pirollo, Kathleen F., Antonina Rait, Willard E. Fee, et al.. (1997). p53 mediated sensitization of squamous cell carcinoma of the head and neck to radiotherapy. Oncogene. 14(14). 1735–1746. 103 indexed citations
17.
Chang, Esther H., Young‐Ju Jang, Hao Zhou, et al.. (1997). Restoration of the G1 Checkpoint and the Apoptotic Pathway Mediated by Wild-type p53 Sensitizes Squamous Cell Carcinoma of the Head and Neck to Radiotherapy. Archives of Otolaryngology - Head and Neck Surgery. 123(5). 507–512. 34 indexed citations
18.
Chang, Yung‐Nien, et al.. (1995). Effect of Herpes Simplex Virus Thymidine Kinase Expression Levels on Ganciclovir-Mediated Cytotoxicity and the “Bystander Effect”. Human Gene Therapy. 6(11). 1467–1476. 77 indexed citations
19.
Ryan, Patricia C., Ming Lu, & David E. Draper. (1991). Recognition of the highly conserved GTPase center of 23 S ribosomal RNA by ribosomal protein L11 and the antibiotic thiostrepton. Journal of Molecular Biology. 221(4). 1257–1268. 76 indexed citations
20.
Ryan, Patricia C. & David E. Draper. (1989). Thermodynamics of protein-RNA recognition in a highly conserved region of the large-subunit ribosomal RNA. Biochemistry. 28(26). 9949–9956. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Raffaella Ghittoni Breakdown of academic impact, for papers by Ralph F. Hopkins Breakdown of academic impact, for papers by Marco Bestagno Breakdown of academic impact, for papers by Mercedes Porosnicu Breakdown of academic impact, for papers by Maria Ferrantini Breakdown of academic impact, for papers by Purnima Dubey Breakdown of academic impact, for papers by Valeri H. Terry Breakdown of academic impact, for papers by Ezequiel M. Fuentes‐Pananá Breakdown of academic impact, for papers by Isabel Fofana Breakdown of academic impact, for papers by Andrea S. Llera
Rankless by CCL
2026